The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| PRGO | -44.03% | -62.01% | -17.58% | +67% |
| S&P | +12.65% | +91.73% | +13.89% | +1,658% |
Perrigo Co. Plc engages in the provision of self-care products and over-the-counter (OTC) health and wellness solutions. It enhances individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. It operates through the following segments: Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment offers OTC solutions, infant formula, oral care, and contract manufacturing in the U.S, Mexico, and Canada. The CSCI segment includes the self-care business branded in Europe, Australia, the United Kingdom, and parts of Europe and Asia. The company was founded by Luther Perrigo in 1887 and is headquartered in Dublin, Ireland.
Regulators just ruled that one of its products can be sold over the counter.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $1.04B | -4.1% |
| Gross Profit | $377.50M | -6.8% |
| Gross Margin | 36.19% | -1.0% |
| Market Cap | $3.06B | -14.4% |
| Market Cap / Employee | $0.37M | 0.0% |
| Employees | 8.4K | -8.3% |
| Net Income | $12.70M | 172.2% |
| EBITDA | $192.30M | 1.3% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $432.10M | -70.5% |
| Accounts Receivable | $675.60M | -16.9% |
| Inventory | 1.2K | 8.2% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $3.76B | -15.9% |
| Short Term Debt | $65.00M | -86.2% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -0.27% | 1.1% |
| Return On Invested Capital | -0.92% | -0.7% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $29.80M | 97.4% |
| Operating Free Cash Flow | $51.70M | 22.5% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 0.77 | 0.89 | 0.84 | 0.69 | -12.95% |
| Price to Sales | 0.81 | 0.89 | 0.85 | 0.70 | -13.31% |
| Price to Tangible Book Value | -2.31 | -2.68 | -2.49 | -1.95 | -20.20% |
| Price to Free Cash Flow TTM | 38.41 | 150.93 | 36.68 | 26.51 | -99.10% |
| Enterprise Value to EBITDA | 33.39 | 44.29 | 45.76 | 33.14 | -10.22% |
| Free Cash Flow Yield | 2.6% | 0.7% | 2.7% | 3.8% | 10987.81% |
| Return on Equity | -3.5% | -3.6% | -1.3% | -0.6% | -79.55% |
| Total Debt | $3.80B | $3.80B | $3.83B | $3.83B | -22.59% |
No podcast episodes available.
PRGO earnings call for the period ending September 30, 2021.
PRGO earnings call for the period ending July 3, 2021.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
